Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,461–7,480 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0938-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

NEOSTIGMINE METHYL SULFATE 1MG/ML INJ SOL SYR, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0143-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0917-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SYR C-IV, 55 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-55

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MIDAZOLAM 1MG/ML IN NACL 0.9% INJ SOL SYR (C-IV), 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0135-86

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MIC (METHIONINE/INOSITOL/CHOLINE CHLORIDE) 25/50/50 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0100-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

METHYLCOBALAMIN 1 MG/ML (MDV) INJECTABLE SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0915-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

MAGNESIUM 200 MG/ML/ CALCIUM GLUC 6MG/ML/ ZINC 1MG/ML, 5ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0176-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

LIDOCAINE HCL 1% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0174-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

KETAMINE 50 MG/ML (NPV) INJECTION SOLUTION (C-III), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Inositol/Choline B12:B6, 50/50/1/0.175 MG/ML INJ SOLN(Sulfa Free Lipostat), 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0999-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

GLUTATHIONE 200MG/ML (PFV) INJECTION SOLN, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0971-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

FOLIC ACID 5MG/ML INJECTION SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0924-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

EPINEPHrine 1:1000 INJECTION SOLUTION (PF) Syringe, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0947-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

EDETATE DISODIUM 15% INJECTABLE, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0922-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

EDETATE CALCIUM DISODIUM 150MG/ML INJECTABLE, 100 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0934-11

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0904-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0946-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

Copper 0.4MG/ML (PVF) INJECTION SOLUTION, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0925-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

BUFFERED LIDOCAINE 1%+EPI 1:100,000 INJ SOL, [3ML NDC: 70731-0137-03 and 30ML NDC: 70731-0137-30] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0137-03

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.